Osteosarcoma in Patients Older than 40 Years

40대 이후에 발생한 골육종

  • Rhee, Seung-Koo (Department of Orthopaedic Sugery, Tumor Research Group, College of Medicine, The Catholic University of Korea) ;
  • Woo, Yong-Kyun (Department of Orthopaedic Sugery, Tumor Research Group, College of Medicine, The Catholic University of Korea) ;
  • Kang, Yong-Koo (Department of Orthopaedic Sugery, Tumor Research Group, College of Medicine, The Catholic University of Korea) ;
  • Song, Seok-Whan (Department of Orthopaedic Sugery, Tumor Research Group, College of Medicine, The Catholic University of Korea) ;
  • Chung, Yang-Guk (Department of Orthopaedic Sugery, Tumor Research Group, College of Medicine, The Catholic University of Korea) ;
  • Lee, An-Hi (Department of Clinical Pathology, College of Medicine, The Catholic University of Korea) ;
  • Yoo, Jin-Young (Department of Clinical Pathology, College of Medicine, The Catholic University of Korea) ;
  • Chung, Do-Hyun (Department of Orthopaedic Sugery, Tumor Research Group, College of Medicine, The Catholic University of Korea)
  • 이승구 (가톨릭대학교 의과대학 정형외과학교실, 골종양 연구회) ;
  • 우영균 (가톨릭대학교 의과대학 정형외과학교실, 골종양 연구회) ;
  • 강용구 (가톨릭대학교 의과대학 정형외과학교실, 골종양 연구회) ;
  • 송석환 (가톨릭대학교 의과대학 정형외과학교실, 골종양 연구회) ;
  • 정양국 (가톨릭대학교 의과대학 정형외과학교실, 골종양 연구회) ;
  • 이안희 (가톨릭대학교 의과대학 임상병리학교실) ;
  • 유진영 (가톨릭대학교 의과대학 임상병리학교실) ;
  • 정도현 (가톨릭대학교 의과대학 정형외과학교실, 골종양 연구회)
  • Published : 1999.09.30

Abstract

Osteosarcoma in patients older than 40 years are rare, however they have different clinical, radiological and pathological features from those of younger patients. Sometimes accurate histologic diagnosis is not easy, which is important in determining the correct surgical treatment and appropriate chemotherapy. Since January 1995, 11 patients with osteosarcoma occurring in patients older than 40 years have been diagnosed, treated and followed up for more than 6 months. In contrast to osteosarcoma in children and adolescents, only 4 cases(36.4%) were conventional types, while the others included 2 malignant fibrous histiocytoma-like types, 2 small cell types, 2 periosteal osteosarcomas and 1 giant cell-rich type. Seven cases showed purely osteolytic or predominantly osteolytic bony lesions and 8 were in Enneking stage IIB. Performed surgical treatments included 2 amputations, 6 wide resections and reconstructions, and one curettage and autogenous bone graft. In the remaining 2 cases, definitive surgical treatments included not carried out because of old age, multifocal involvement or poor medical tolerance. Neoadjuvant and adjuvant chemotherapies were performed in 9 of 11 patients. At last follow-up, there were 6 continuously disease-free survivals, 3 alive with diseases and 2 died of diseases. The overall cumulative 4-year survival rate calculated using Kaplan-Meier's productlimit method was 59.3%. For improved oncologic outcomes and survivals, early and accurate diagnosis, surgical treatment with adequate margin and neoadjuvant and adjuvant chemotherapy will be necessary.

Keywords

Acknowledgement

Supported by : 가톨릭중앙의료원